Doctor profile · Federal record
Dr. SHIVA KUMAR MUKKAMALLA, MD, MPH
Hematology (Internal Medicine) Physician (CMS: MEDICAL ONCOLOGY) · Student in an Organized Health Care Education/Training Program · INDIANA, PA
- NPI 1013268077
- Accepts Medicare
- MIPS 83.0 / 100 · 2023
- 17 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
IRMC CANCER CENTER 850 HOSPITAL ROAD FIRST FLOOR, SUITE 1300
INDIANA, PA 15701
(724) 349-9444 - Mailing address
-
IRMC CANCER CENTER 850 HOSPITAL ROAD, SUITE 1300
INDIANA, PA 15701
Credentials & registration
- NPI registered
- September 2012 — 14 yrs on file
- Profile last updated
- March 25, 2024
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RH0000X — NUCC code
- State license (1)
- New Mexico #MD2017-0778
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1013268077. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
818
Distinct HCPCS
6
Medicare allowed
$99,827
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 396 | 123 | $139 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 285 | 179 | $96 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 55 | 21 | $117 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 32 | 32 | $170 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 28 | 27 | $65 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 22 | 22 | $171 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 136. This provider delivers 6.0× the peer median.Open Payments
Industry payments received
All-time total
$3,001
Transactions
10
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| BeiGene USA, Inc. | 1 | $2,250.00 | |
| Daiichi Sankyo Inc. | 2 | $545.04 | |
| Janssen Biotech, Inc. | 1 | $99.99 | |
| Merck Sharp & Dohme LLC | 2 | $36.18 | |
| ABBVIE INC. | 2 | $31.56 | |
| Gilead Sciences, Inc. | 1 | $21.65 | |
| Rigel Pharmaceuticals, Inc. | 1 | $16.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,385
Patients
402
Total drug cost
$1,061,731
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 236 | 69 | $8,529 |
| Letrozole | Generic | 163 | 44 | $6,217 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 103 | 23 | $4,930 |
| Prednisone | Generic | 102 | 35 | $687 |
| Xarelto (Rivaroxaban) | Brand | 102 | 33 | $94,597 |
| Abiraterone Acetate | Generic | 98 | 16 | $156,765 |
| Potassium Chloride | Generic | 85 | 31 | $7,335 |
| Prochlorperazine Maleate | Generic | 80 | 42 | $1,734 |
| Gabapentin | Generic | 77 | 17 | $505 |
| Eliquis (Apixaban) | Brand | 73 | 14 | $52,184 |